183 related articles for article (PubMed ID: 15543320)
1. Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.
Sutherland MR; Friedman HM; Pryzdial EL
Thromb Haemost; 2004 Nov; 92(5):947-55. PubMed ID: 15543320
[TBL] [Abstract][Full Text] [Related]
2. Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes.
Lin BH; Sutherland MR; Rosell FI; Morrissey JH; Pryzdial ELG
J Thromb Haemost; 2020 Jun; 18(6):1370-1380. PubMed ID: 32145149
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding.
Livingston JR; Sutherland MR; Friedman HM; Pryzdial EL
Biochem J; 2006 Jan; 393(Pt 2):529-35. PubMed ID: 16212554
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection.
Sutherland MR; Ruf W; Pryzdial EL
Blood; 2012 Apr; 119(15):3638-45. PubMed ID: 22374699
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
6. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
7. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
Hoffman M; Monroe DM
Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
9. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
Thiec F; Cherel G; Christophe OD
J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
[TBL] [Abstract][Full Text] [Related]
11. Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor.
Persson E
Thromb Res; 2008; 123(1):171-6. PubMed ID: 18550154
[TBL] [Abstract][Full Text] [Related]
12. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
Furukawa S; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
[TBL] [Abstract][Full Text] [Related]
13. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
[TBL] [Abstract][Full Text] [Related]
14. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
15. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.
Huang Q; Neuenschwander PF; Rezaie AR; Morrissey JH
J Biol Chem; 1996 Sep; 271(36):21752-7. PubMed ID: 8702971
[TBL] [Abstract][Full Text] [Related]
16. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
17. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC
J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
20. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
